In the past week, TMDX stock has gone up by 11.29%, with a monthly decline of -0.12% and a quarterly surge of 15.26%. The volatility ratio for the week is 4.39%, and the volatility levels for the last 30 days are 4.90% for Transmedics Group Inc The simple moving average for the last 20 days is 5.45% for TMDX stock, with a simple moving average of 46.08% for the last 200 days.
Is It Worth Investing in Transmedics Group Inc (NASDAQ: TMDX) Right Now?
Transmedics Group Inc (NASDAQ: TMDX) has a higher price-to-earnings ratio of 4649.30x compared to its average ratio. TMDX has 36-month beta value of 2.00. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TMDX is 32.23M, and currently, short sellers hold a 18.22% ratio of that float. The average trading volume of TMDX on September 20, 2024 was 791.44K shares.
TMDX) stock’s latest price update
Transmedics Group Inc (NASDAQ: TMDX) has seen a rise in its stock price by 6.42 in relation to its previous close of 155.96. However, the company has experienced a 11.29% gain in its stock price over the last five trading sessions. zacks.com reported 2024-09-16 that Invest in stocks of TMDX, IAG, GHM and GIII to tap their high-efficiency levels.
Analysts’ Opinion of TMDX
Many brokerage firms have already submitted their reports for TMDX stocks, with Needham repeating the rating for TMDX by listing it as a “Buy.” The predicted price for TMDX in the upcoming period, according to Needham is $208 based on the research report published on August 21, 2024 of the current year 2024.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see TMDX reach a price target of $161. The rating they have provided for TMDX stocks is “Overweight” according to the report published on June 06th, 2024.
Stephens gave a rating of “Overweight” to TMDX, setting the target price at $151 in the report published on June 04th of the current year.
TMDX Trading at 7.67% from the 50-Day Moving Average
After a stumble in the market that brought TMDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.42% of loss for the given period.
Volatility was left at 4.90%, however, over the last 30 days, the volatility rate increased by 4.39%, as shares sank -4.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.82% upper at present.
During the last 5 trading sessions, TMDX rose by +11.29%, which changed the moving average for the period of 200-days by +122.31% in comparison to the 20-day moving average, which settled at $157.06. In addition, Transmedics Group Inc saw 110.29% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMDX starting from Hassanein Waleed H, who sale 8,625 shares at the price of $153.42 back on Sep 16 ’24. After this action, Hassanein Waleed H now owns 61,643 shares of Transmedics Group Inc, valued at $1,323,210 using the latest closing price.
Khayal Tamer I, the Chief Commercial Officer of Transmedics Group Inc, sale 2,960 shares at $159.60 during a trade that took place back on Sep 03 ’24, which means that Khayal Tamer I is holding 20,843 shares at $472,404 based on the most recent closing price.
Stock Fundamentals for TMDX
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.61 for the gross margin
The net margin for Transmedics Group Inc stands at 0.01. The total capital return value is set at -0.0. Equity return is now at value 1.79, with 0.41 for asset returns.
Based on Transmedics Group Inc (TMDX), the company’s capital structure generated 0.73 points at debt to capital in total, while cash flow to debt ratio is standing at 0.05. The debt to equity ratio resting at 2.69. The interest coverage ratio of the stock is -0.06.
Currently, EBITDA for the company is 8.76 million with net debt to EBITDA at 9.1. When we switch over and look at the enterprise to sales, we see a ratio of 15.86. The receivables turnover for the company is 4.42for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.37.
Conclusion
To put it simply, Transmedics Group Inc (TMDX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
